MRKR is trading 5.4% up at $1.56 today, continuing a positive trajectory that began in late June despite a lack of new company-specific catalysts.
- No fresh headlines, earnings reports, FDA decisions, or analyst calls have been identified to explain the current price action.
- The move appears to be driven by typical volatility in a thinly traded micro-cap biotech stock, occurring against a slightly weaker broader market backdrop.